Valued : Actualité Valued en direct - P1 | Bourse Reflex
Accueil > Tags > Valued

  • Toutes les actualités en rapport avec « Valued »

02/05 07:30 Valued - ORAL PRESENTATION OF THERANEXUS AT THE 9TH EUROPEAN CONGRESS ON NARCOLEPSY 5 AND 6 MAY IN MONTPELLIER

23/04 07:30 Valued - THN102 OBTAINS INVESTIGATIONAL NEW DRUG STATUS FROM THE FOOD AND DRUG ADMINISTRATION (FDA)

19/04 18:00 Valued - THERANEXUS ANNOUNCES THE FIRST EUROPEAN APPROVAL FOR ITS PHASE 2 CLINICAL TRIAL WITH THN 102 IN PARKINSON'S DISEASE PATIENTS

19/04 17:45 Valued - Quantum Genomics enters a new phase of maturity with its BAPAIs Fast Growth strategic plan

12/03 17:45 Valued - 2017 RESULTS

08/03 17:50 Valued - Altamir's NAV per share was EUR 21.54 as of 31 December 2017

08/11 17:45 Valued - Altamir maintained its investment momentum in third-quarter 2017

15/09 18:00 Valued - HALF-YEAR RESULTS TO 30 JUNE 2017

05/09 17:45 Valued - Increase in NAV including the dividend and very good portfolio turnover in H1 2017

04/07 19:30 Valued - OPENING OF THE PUBLIC TENDER OFFER FOR FUTUREN

30/06 13:05 Valued - Artprice takes a major stake in the OTC Art Market which generates a volume of transactions roughly 7 to 9 times higher than the traditional art market

11/05 17:45 Valued - Altamir posts an increase in NAV over the first three months of the year

10/04 18:00 Valued - Signing of the agreements relating to the acquisition of PAREF by Fosun

10/03 16:00 Valued - 2016 ANNUAL RESULTS

08/03 18:00 Valued - Altamir concludes a record year for divestments and value creation in the portfolio

08/03 08:30 Valued - 2016 RESULTS

21/02 08:00 Valued - Global EcoPower welcomes its newest shareholder, the portfolio management company MCA FINANCE, through reserved capital increase

15/12 09:45 Valued - FIGEAC AERO, 2016/2017 FIRST HALF-YEAR RESULTS

07/12 08:50 Valued - FIGEAC AÉRO RECEIVES THE "SHOWCASE OF FUTURE INDUSTRY"

03/11 18:00 Valued - Increase in NAV and further divestments for Altamir in Q3 2016